Navigation Links
New Best Practices, LLC Study Examines Use of Health Outcomes Data in Marketplace
Date:6/28/2011

CHAPEL HILL, N.C., June 28, 2011 /PRNewswire/ -- Optimizing the use of Health Outcomes data is increasingly important to the success of biotechnology and pharmaceutical companies. While organizations commonly use Health Outcomes data, companies have different approaches for how functions like Medical Science Liaisons and Managed Care Account Managers utilize the data.

To help organizations understand current approaches to effectively utilizing Health Outcomes data in the marketplace, Best Practices, LLC has published a study that examines the internal and external uses of Health Outcomes data for promotional and strategic purposes. The study, Best Practices in Utilizing Health Outcomes Data, provides comparative data from 2009 and 2011 that illustrates shifting attitudes for how organizations use Health Outcomes data.

In 2011 and 2009, reimbursement and drug formulary decisions were the main use of Health Outcomes data for the Managed Care function, according to the study. There was a shift, however, in how extensively organizations use Health Outcomes data internally for reimbursement decisions - 45 percent in 2009 versus 69 percent in 2011.

The 48-page study reflects current approaches to Health Outcomes data utilization at 16 biopharma organizations; the 2009 data is based on a benchmark class of 29 companies.

The insights in this new study will help pharmaceutical and biotech organizations compare their use of Health Outcomes data in promotional and internal settings with that of leading organizations. The study also examines the pressing Regulatory issues raised by the different uses of Health Outcomes data.

Key topics covered in this research include:

  • Structure and Reporting Lines of Authority
  • Use of Health Outcomes Data Proactively and Retrospectively
  • How Health Outcomes Data is Utilized within Different Groups
  • Health Outcomes Review Process and Structure
  • Best Practices in Health Outcomes Utilization

To download a complimentary study excerpt, go to: http://www3.best-in-class.com/rr1086.htm.

ABOUT BEST PRACTICES, LLC

Best Practices, LLC serves 48 of the world's 50 top pharmaceutical companies. For 17 years, we have conducted work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information about the company, go to www.best-in-class.com.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Research from Best Practices, LLC can Improve Formulary Access and Product Placement for Biopharma Companies: Managed Markets Market Research
2. As Biopharma Companies Reshape Sales Model, Most See Resetting Territory Size and Implementing Individualized Call Plans as First Steps Toward Change, According to New Research From Best Practices, LLC
3. New Research from Best Practices, LLC Helps Medical Device Companies Earn the Highest Profit Possible During Their Products Patent Lifecycle
4. Research from Best Practices, LLC Delivers Blueprint for Commercial Success of New Product Planning Groups
5. Best Practices, LLC Report on Post-Marketing Surveillance Programs Sheds Light on Gray Areas of Adverse Event Reporting
6. Best Practices, LLC Research Highlights Critical Role of Medical Marketing in New Product Launch Success
7. Best Practices, LLC Research Highlights Evolving Role of Market Research in Organizational Success
8. Research from Best Practices, LLC Delivers Effective Market Education Tactics and Strategies for New Oncology Products
9. Best Practices, LLC Research Highlights Critical Role of Medical Affairs in New Product Launch Success
10. Professional Relations Excellence Outlined in New Best Practices, LLC Report
11. Medical Affairs Role in New Product Planning Detailed in Best Practices, LLC Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... LOS ANGELES , June 23, 2016 /PRNewswire/ ... (NASDAQ: CAPR ), a biotechnology company ... first-in-class therapeutics, today announced that patient enrollment in ... progrEssion in Duchenne) has exceeded 50% of its ... its enrollment in the third quarter of 2016, ...
(Date:6/23/2016)... Pa. , June 23, 2016 Bracket ... will launch its next generation clinical outcomes platform, Bracket eCOA ... Meeting held on June 26 – 30, 2016 in ... the first electronic Clinical Outcome Assessment product of its kind ... Booth #715. Bracket eCOA 6.0 is a flexible ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... To deal with these feelings, many turn to unhealthy avenues, such as drug or ... Center of Marne, Michigan, has released tools for healthy coping following a traumatic event. ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):